Feb 24, 2021





GLP-1 agonist Exenatide “GLP-1″ can support weight loss and is an appetite suppressant. It can be combined with AOD-9604 to extreme weight loss support.

GLP-1 is a peptide hormone that increases insulin secretion and decreases glucagon secretion from the pancreas in a glucose-dependent manner. GLP-1 RAs provide pharmacologic levels of GLP-1, which reduces glucose and weight by increasing glucose-dependent insulin secretion and decreasing glucagon secretion, delaying gastric empyting, and increasing satiety.

overhead shot of weight scale, water bottle, running shoes, fruit, and dumbells

Doctors suggest that GLP-1s appear to help suppress appetite. This peptide slows the movement of food from the stomach into the small intestine. As a result, you may feel full faster and longer, so you eat less.

GLP-1 mimics the action of a hormone called glucagon-like peptide 1. When blood sugar levels start to rise after someone eats, this medication can stimulate the body to secrete more insulin. The extra insulin helps lower blood sugar levels. Lower blood sugar levels help control type 2 diabetes.

Diabetes and Weight Loss

Globally, it is estimated that 382 million people have diabetes, correlating with a prevalence of 8.3%. Type 2 diabetes (T2D) accounts for approximately 95% of all cases. Coinciding with the growing rates of obesity, the global prevalence of T2D continues to rise. T2D increases the risk of heart attacks and strokes, kidney failure, blindness, and amputations if inadequately treated. The GLP-1 peptide is an attractive option for the treatment of T2D because it effectively lowers A1C and weight while having a low risk of hypoglycemia.

doctor's hands holding an graphic of healthy bowels

How It Works

GLP-1 is released from the distal ileum and colon within minutes of a meal and, while it does enhance glucose-dependent insulin production and secretion, it has also been shown to decrease glucagon secretion, increase glucose uptake and glycogen synthesis in peripheral tissues, delay gastric emptying, and increase satiety, making it an ideal target for diabetes therapy.

In addition to bodyweight reduction and lower systolic blood pressure, all GLP-1 receptor agonists slightly but favorably modify lipoprotein concentrations (lowering LDL cholesterol and triglycerides).


A month’s supply is 600mcg vial and someone will be taking at max 20mcg per day daily.

Call Core Medical Group today at 561-243-1219 or contact us online to schedule your private, personal consultation.

Post by admin

Comments are closed.